Dr. Priya Nandakumar brings scientific and clinical insight to BioIntel’s coverage of biomedical research and healthcare innovation. Her work bridges experimental findings, clinical data, and industry strategy, helping readers interpret what new evidence means beyond the lab or trial setting. At BioIntel, Priya emphasizes translational relevance and long-term implications for patients and pipelines.